MedTrace Logo

Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome

NCT01863017 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2019-04-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effects of transcranial direct current stimulation (tDCS) as it modifies hyperphagia in obese subjects, non-obese subjects, and subjects with Prader-Willi syndrome (PWS).

Conditions

Interventions

DEVICE

tDCS

Sponsors & Collaborators

  • Prader-Willi Syndrome Association USA

    collaborator OTHER

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Foundation for Prader-Willi Research

    collaborator OTHER

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Merlin G. Butler, MD, PhD · University of Kansas Medical Center

  • Felipe Fregni, MD, PhD, MPH · Spaulding Rehabilitation Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-10-06
Completion
2016-10-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01863017 on ClinicalTrials.gov